Pre-dementia study, MCI, Alzheimer, APOE-4, recruiting
Summary
The National Library of Medicine registered a new clinical trial on ClinicalTrials.gov (NCT07516119) studying pre-dementia and mild cognitive impairment in participants with Alzheimer's disease and APOE-4 genetic markers. The study is currently recruiting participants. ClinicalTrials.gov serves as the federal registry for clinical trials required under FDAAA 801.
What changed
This document represents a new clinical trial registration on ClinicalTrials.gov, the federal clinical trial registry operated by the National Library of Medicine. The study focuses on pre-dementia and mild cognitive impairment (MCI) in participants with Alzheimer's disease who carry the APOE-4 genetic marker.
For sponsors, clinical investigators, and healthcare providers, this registration represents the standard federal requirement for publicly disclosing clinical trial information. Researchers studying similar neurodegenerative conditions should ensure their trials are properly registered on ClinicalTrials.gov and maintain compliance with FDAAA 801 reporting obligations.
What to do next
- Monitor ClinicalTrials.gov for enrollment updates
- Review eligibility criteria for potential study participation
- Ensure compliance with ClinicalTrials.gov registration requirements if sponsoring similar trials
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NLM.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.